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Mammalian cytochrome c (Cytc) plays a key role in cellular
life and death decisions, functioning as an electron carrier in the
electron transport chain and as a trigger of apoptosis when
released from the mitochondria. However, its regulation is not
well understood. We show that the major fraction of Cytc iso-
lated from kidneys is phosphorylated on Thr28, leading to a par-
tial inhibition of respiration in the reaction with cytochrome c
oxidase. To further study the effect of Cytc phosphorylation in
vitro, we generated T28E phosphomimetic Cytc, revealing supe-
rior behavior regarding protein stability and its ability to
degrade reactive oxygen species compared with wild-type un-
phosphorylated Cytc. Introduction of T28E phosphomimetic
Cytc into Cytc knock-out cells shows that intact cell respiration,
mitochondrial membrane potential (m), and ROS levels are
reduced compared with wild type. As we show by high resolu-
tion crystallography of wild-type and T28E Cytc in combination
with molecular dynamics simulations, Thr28 is located at a cen-
tral position near the heme crevice, the most flexible epitope of
the protein apart from the N and C termini. Finally, in silico
prediction and our experimental data suggest that AMP kinase,
which phosphorylates Cytc on Thr28 in vitro and colocalizes
with Cytc to the mitochondrial intermembrane space in the kid-
ney, is the most likely candidate to phosphorylate Thr28 in vivo.
We conclude that Cytc phosphorylation is mediated in a tissue-
specific manner and leads to regulation of electron transport
chain flux via “controlled respiration,” preventing m hyper-
polarization, a known cause of ROS and trigger of apoptosis.
Cytochrome c (Cytc)2 is a small (12-kDa) globular nucleus-
encoded mitochondrial protein containing a covalently at-
tached heme group with multiple functions. In the electron
transport chain (ETC), it functions as a single electron carrier
between bc1 complex (complex III) and cytochrome c oxidase
(CcO, complex IV) and is thus essential for aerobic energy pro-
duction. The second important role of Cytc is seen under con-
ditions of stress, when it functions as a crucial pro-apoptotic
signal (1). During apoptosis, Cytc is released from mitochondria
into the cytosol, where it interacts with Apaf-1 to form the
apoptosome, which in turn activates caspase-9 and the down-
stream executioner caspase cascade. Furthermore, Cytc func-
tions as a cardiolipin peroxidase during the early phase of apo-
ptosis, when it oxidizes the mitochondrial membrane lipid
cardiolipin, thereby facilitating its own release from the inner
mitochondrial membrane (2). In contrast, under healthy, non-
apoptotic conditions, Cytc acts as a scavenger of reactive oxy-
gen species (ROS) (3), and it takes part in other redox reactions
inside mitochondria, including redox-coupled protein import
(4) and reduction of p66Shc, a protein that is implicated in the
generation of ROS and apoptosis (5).
Given the multiple functions of Cytc, it is not surprising that
it is tightly regulated. Two regulatory mechanisms via expres-
sion of a somatic and testis-specific isoform pair and allosteric
regulation through binding of ATP have been known for over
30 years (6, 7). A third mechanism via reversible phosphoryla-
tion was discovered recently when we purified bovine Cytc
from heart and liver tissue under conditions preserving the
physiological phosphorylation status. The two proteins were
phosphorylated on Tyr97 and Tyr48, respectively (8, 9). Both
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modifications lead to a partial inhibition of respiration. In addi-
tion, the phosphomimetic Y48E substitution abolished the
capabilityofCytc totriggerapoptosis, suggestingthatCytcphos-
phorylation regulates apoptosis at the level of the apoptosome
(10).
Here we report that Cytc purified from bovine and rat kidney
tissues in the presence of phosphatase inhibitors is phosphory-
lated on Thr28. In vivo phosphorylated and T28E phosphomi-
metic Cytc led to an inhibition of respiration in the reaction
with CcO. Introduction of WT and T28E phosphomimetic Cytc
into Cytc knock-out cells showed that intact cell respiration,
mitochondrial membrane potential (m), and ROS levels
were reduced. This suggests that Cytc phosphorylation can reg-
ulate ETC flux, preventing m hyperpolarization, a known
trigger of ROS production and apoptosis (11). Finally, we pro-
vide evidence suggesting that phosphorylation of Thr28 is medi-
ated by AMP kinase (AMPK), which co-localizes with Cytc in
the mitochondrial intermembrane space. This is the first report
of a mapped phosphorylation site on a mammalian oxidative
phosphorylation component, together with functional and
structural analyses and a kinase candidate mediating this site-
specific modification.
Results
Mammalian Kidney Cytochrome c Is Phosphorylated on
Thr28, Leading to “Controlled Respiration”—To test whether
Cytc phosphorylation occurs in mammalian tissues other than
the heart and liver, where it is tyrosine-phosphorylated, we
chose the kidney, an organ with a high mitochondrial capacity
and the second highest oxygen consumption rate only after
heart (12). Surprisingly, Western blotting analysis of Cytc from
bovine kidney detected phosphorylation on threonine (Fig. 1A)
FIGURE 1. Kidney cytochrome c is phosphorylated on threonine 28, leading to controlled respiration. A, purification of cow kidney Cytc indicates
threonine phosphorylation. Lane 1, kidney Cytc; lane 2, cow heart Cytc (Sigma); lane 3, ovalbumin (Western negative control); lane 4, EGF-treated A431 total cell
lysate (Western blotting positive control). Top, Coomassie gel; bottom, anti-phospho-Thr Western blot. B, nano-LC/ESI/MS/MS spectrum of HKpTGPNLHGLFGR
reveals phosphorylation of Thr28. The phosphorylation site was unambiguously assigned by fragment ions y10 and y11. The sequence of the peptide was
assigned by b2, b8, b9, y1, y2, y4, y5, y6, y8, y9, and y10. C, in vitro cytochrome c oxidase activity with in vivo phosphorylated Thr28 (pT28) is 50% reduced at
maximal turnover compared with unphosphorylated Cytc. D, top, high resolution gel electrophoresis indicates that 83% of the Cytc pool is phosphorylated
(lane 1, top band); bottom band, unphosphorylated Cytc. Lane 2, nonspecific phosphatase treatment of Cytc collapses the top band. Bottom, Western blotting
with an anti-phosphothreonine antibody indicates dephosphorylation of Cytc in lane 2. Error bars, S.D.
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but not on tyrosine (not shown). Mass spectrometry unambig-
uously revealed that Thr28 was phosphorylated in three inde-
pendent Cytc isolations analyzed (Fig. 1B). This amino acid is
conserved in mammals, both in the somatic and testes-specific
isoform (supplemental Fig. 1A). To test the effect of Thr28 phos-
phorylation, we measured the kinetics of in vivo phosphorylated
Cytc with isolated CcO. Oxygen consumption was 50% lower at
maximal turnover for Thr28-phosphorylated versus unphos-
phorylated Cytc (Fig. 1C). Phosphorylation of Thr28 also
dropped the apparent Km of Cytc in the reaction with CcO from
6.3 to 4.5 M. Similar to Tyr48 and Tyr97 phosphorylation,
Thr28 phosphorylation leads to partial inhibition of respiration,
which we propose prevents m hyperpolarization and thus
ROS production under non-stressed conditions and have
therefore called “controlled respiration.”
For a posttranslational modification to be biologically rele-
vant, a significant fraction of the protein should carry the mod-
ification. Using high resolution gel electrophoresis, which sep-
arates phosphorylated and unphosphorylated Cytc, we found
that 80% of the Cytc pool was phosphorylated (Fig. 1D, lane 1,
top band).
Overexpression and Purification of Functional and Correctly
Folded Cytochrome c Variants in Escherichia coli Cells—We
and others have previously shown for tyrosine-phosphorylated
Cytc that phosphomimetic replacement of the phosphorylat-
able residue with the negatively charged glutamate produces
functional effects similar to those seen with the in vivo phos-
phorylated protein (10, 13). We thus generated the following
Cytc variants based on the mouse sequence and overexpressed
them in E. coli BL21 (DE3) cells: WT, phosphomimetic T28E,
and T28A Cytc as an additional control that cannot be phos-
phorylated. The purity of Cytc was confirmed by Coomassie
staining (Fig. 2A) and spectrophotometric analysis, with 410
nm/280 nm ratios 4 (10). All three proteins were fully
reducible and correctly folded, as shown by absorption spec-
tra measurements (supplemental Fig. 1B) and circular dichro-
ism (supplemental Fig. 1C). Similar to our previous study (10),
none of the bacterially overexpressed proteins were Ser-, Thr-,
or Tyr-phosphorylated (not shown). The redox midpoint
potential of Cytc is approximately midway between the redox
potentials of complexes III and IV, and values reported in the
literature range from 220 to 270 mV (14). The redox potentials
for WT, T28A, and T28E were 246, 221, and 217 mV (Fig. 2B),
suggesting that a modification on position 28 lowers the redox
potential of Cytc, similarly to phosphomimetic Y48E Cytc (10).
Phosphomimetic Cytc Displays a Significantly Decreased
Reaction Rate with Isolated CcO—We showed that in vivo phos-
phorylated Cytc displayed an 50% inhibition in the reaction
with isolated bovine liver CcO (Fig. 1C). To demonstrate that
T28E is a good model for Thr28-phosphorylated Cytc, we first
analyzed its activity in the reaction with purified CcO. As
shown in Fig. 2C, we found that respiration rates of phospho-
mimetic T28E and T28A Cytc were 73 and 51% reduced,
respectively, indicating that T28E Cytc serves as a useful model.
The apparent Km of Cytc in the reaction with CcO was 7.8, 9.3,
and 4.7 M for unphosphorylated WT, T28E, and T28A Cytc,
respectively. The fact that the inhibitory effect of the phospho-
mimetic substitution is even more pronounced than that
observed with in vivo phosphorylated Cytc may be due to the
subfraction (about 20%) of unphosphorylated Cytc present
when isolated from kidneys. The finding that T28A Cytc also
differs from the WT suggests an unexpected structural sensi-
tivity of the reaction to the precise residue at position 28 in Cytc
(see “Discussion”).
T28E Cytc Can Trigger Caspase-3 Activation but Shows Dis-
tinct Features in its ROS-related Functions—To test the possi-
ble effect of Thr28 phosphorylation on apoptotic function, we
analyzed the ability of the Cytc variants to trigger apoptosis by
measuring downstream activation of caspase-3 using a cell-free
caspase assay. Cytc mutants were incubated with cytosolic frac-
tions prepared from mouse lung fibroblasts in which both the
somatic and testes-specific isoforms of Cytc were knocked out
(15). The T28E mutant was able to activate caspase-3 similarly
to wild-type Cytc protein (Fig. 2D) and Thr28-phosphorylated
Cytc (supplemental Fig. 2), indicating that Thr28 phosphoryla-
tion of Cytc does not affect the function of Cytc at the level of
apoptosome formation. Other functions of Cytc include ROS
scavenging, such as reduction by superoxide to regenerate oxy-
gen or oxidation by H2O2. We therefore tested the ability of
Cytc in the reaction with H2O2 and with the reductant ascor-
bate. To analyze the former, ferro-(Fe2)-Cytc variants were
oxidized in the presence of 100 M H2O2. The T28E phospho-
mimetic mutant was oxidized at a rate similar to WT Cytc,
whereas the T28A mutant was oxidized at a 2.7-fold higher rate
(Fig. 2E). At higher ROS load, Cytc can lose its functionality
through oxidative modifications, which can be monitored
through a decrease in the absorption of the heme Soret band at
408 nm present in intact Cytc. After the addition of excess H2O2
(3 mM) T28E Cytc was more resistant to degradation by excess
H2O2 than the wild type, whereas the T28A mutant was
degraded more rapidly (Fig. 2F), suggesting that the introduc-
tion of a negative charge in position 28 stabilizes the protein. To
determine the rate of Cytc reduction, ferri-(Fe3)-Cytc variants
were reduced in the presence of 200 M ascorbate. T28E Cytc
was reduced at about twice the rate of WT or T28A Cytc (Fig.
2G), suggesting that it can act as a superior electron acceptor
and scavenger.
Cardiolipin (CL) oxidation is a pro-apoptotic function of
Cytc. Native Cytc has a low degree of peroxidase activity, which
increases when CL binds to Cytc, causing partial unfolding (16).
To assess the peroxidase activity of Cytc, the rate of Amplex Red
oxidation by CL-peroxide was analyzed in the presence of
H2O2. H2O2 is a poor substrate for Amplex Red oxidation,
whereas oxidized CL species are good substrates. At higher
tetralinoleyl-CL (TOCL)/Cytc ratios, T28E Cytc showed signif-
icantly reduced peroxidase activity compared with WT (Fig.
2H). Interestingly, the T28A mutant had the highest peroxidase
activity at all ratios, suggesting that it unfolds more easily com-
pared with WT and T28E Cytc.
High Resolution X-ray Crystallography and Molecular
Dynamics Reveal Structural Features of the Thr28 Epitope—To
gain a better understanding of the structure-function relation-
ship of the Thr28 epitope, we crystalized all three mouse Cytc
variants under oxidizing conditions and obtained crystals that
diffracted at a resolution of 1.12, 1.36, and 1.30 Å for WT, T28A,
and T28E Cytc, respectively. The WT structure has the highest
Cytochrome c Thr28 Phosphorylation
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resolution of any mammalian Cytc structure. As expected, the
crystal structures of WT, T28A, and T28E are similar overall
(Fig. 3, A, D, and G, and supplemental Table 1). To explore
possible differences in their solution structures, molecular
dynamics simulations were performed on the A chain from the
three protein structures as well as on a model of phosphorylated
FIGURE 2. Phosphomimetic T28E Cytc shows unique features in vitro. A, Coomassie gel of bacterially overexpressed and isolated WT, T28E (T28E), and T28A
(T28A) Cytc indicates that the proteins were purified to homogeneity (Sigma; commercially available bovine Cytc as an additional control). B, redox potential
is reduced in the T28E and T28A mutants compared with WT; means  S.D. (error bars) are reported; *, p  0.05. C, O2 consumption rates of cow cytochrome
c oxidase in the reaction with Cytc were 73 and 51% reduced for T28E and T28A Cytc compared with WT. D, in vitro caspase-3 activity is unaltered with T28E Cytc,
whereas it is increased with the T28A mutant. E, oxidation rate of WT and T28E Cytc in the presence of H2O2 is similar, whereas the T28A mutant shows increased
rates. F, compared with WT, loss of the heme group by excess H2O2 is decreased and increased for T28E and T28A Cytc, respectively. Shown are representative
heme destruction curves. G, the T28E Cytc reduction rate in the presence of ascorbate is increased compared with WT and T28A Cytc. H, T28E Cytc-mediated
cardiolipin oxidation is decreased at highest TOCL/Cytc ratios compared with WT and T28A Cytc. AU, arbitrary units.
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Cytc with the phosphate group added to Thr28 in the WT chain
A using COOT (PDB code Tpo28). In all four simulations, the
C chain from the final solution structure after 200 ns super-
posed well with the beginning crystal structure except for the
Thr28-containing loop 22–30 (Fig. 3, A, B, D, E, G, H, J, and K),
which also had the highest root mean square fluctuations
(RMSF) except for the N and C termini (Fig. 3, C, F, I, and L). In
all four simulations, the surface loop adopted an alternate con-
formation, which moved the C atom of residue 28 about 5 Å
from its starting position. Surprisingly, in the T28A simulation,
the loop paused at the same conformation as the others but
then continued to move until it reached a conformation after
200 ns that put Ala28 11.9 Å from its starting position (Fig. 3E).
These differences may explain the structural instability of this
mutant. In contrast, T28E Cytc recapitulates the functional
effects seen with in vivo phosphorylated Cytc. As expected,
electrostatic potential (ESP) calculations show that the T28E
mutant has a negative ESP region that is larger than WT and is
only exceeded by the Thr283Thr(P) model (supplemental Fig.
4, B–D).
Introduction of T28E Cytc into Cytc Double Knock-out Cells
Reduces Oxygen Consumption Rate, Mitochondrial Membrane
Potential, and ROS—To test the effect of phosphomimetic sub-
stitution of Cytc in intact cells on mitochondrial parameters, we
generated cell lines stably transfected with empty vector con-
trol and WT, T28E, and T28A Cytc, using mouse lung fibro-
blasts in which both the somatic and testes-specific Cytc iso-
forms have been knocked out. Double knock-out is required
because cultured mouse cells lacking somatic Cytc induce the
expression of the testes isoform, restoring mitochondrial respi-
ration (15). Expression levels of WT and T28E Cytc were com-
parable between different clones, whereas protein levels of
T28A Cytc were lower compared with the other Cytc variants
(the clone with the highest expression levels was used for sub-
sequent experiments; Fig. 4A), suggesting that higher expres-
sion levels of this mutant may interfere with cellular functions
or that protein turnover is higher. As reported previously (17),
Cytc knock-out interferes with complex I and IV assembly,
which is restored upon reintroduction of the three Cytc variants
(Fig. 4A). Determination of cell growth showed that WT and
T28E Cytc-expressing cells grew equally well, whereas T28A
Cytc-expressing cells showed a 27% reduced growth rate versus
WT (Fig. 4B) (see “Discussion”). We next analyzed intact cell
respiration. Strikingly, cells expressing T28E phosphomimetic
Cytc showed 60% reduced respiration rates (Fig. 4C), matching
results obtained with purified CcO in vitro (Figs. 1C and 2C).
This finding is of importance because it suggests that a modifi-
cation of the small electron carrier Cytc can control overall flux
in the ETC, a scenario that has not been reported or considered
in the past. Consequently, a reduction of the respiration rate
should translate into a reduced mitochondrial membrane
potential m. Analysis with the voltage-dependent probe
JC-1 showed that T28A- and T28E-expressing cells showed 15
and 31% reduced fluorescence compared with WT (Fig. 4D),
indeed indicating a reduction of m. Given the direct connec-
tion of m with ROS production at complexes I and III (18),
we predicted that T28E Cytc-expressing cells should exhibit
reduced ROS levels. Using the mitochondrial ROS probe
MitoSox, we found that fluorescent signals were reduced by
35– 40% in cells expressing T28E and T28A Cytc compared
with WT, indicating reduced ROS levels (Fig. 4E). ATP levels
were reduced by 6 and 28% for cells expressing T28A and T28E,
respectively (Fig. 4F). To test whether cells expressing T28E
Cytc are better protected from H2O2 exposure, cell viability was
determined after treatment with H2O2. T28E Cytc-expressing
cells showed higher viability when treated with a low concen-
tration of H2O2, but viability matched with WT Cytc-express-
ing cells at higher H2O2 concentration (Fig. 4G). This observa-
tion suggests that T28E Cytc protects the cells from mild
oxidative stress. These data suggest that modification of Cytc
Thr28 regulates ETC flux, which in turn affects m and ROS.
AMPK Interacts with and Phosphorylates Cytc on Thr28—To
identify a kinase candidate that targets Cytc for Thr28 phosphor-
ylation, we first used the online tool Scansite (19) for in silico
prediction of possible Cytc binding motifs of signaling mole-
cules. Interestingly, Thr28 was predicted to be an AMPK phos-
phorylation site. The epitope has several features identified in
known AMPK targets, including a lysine in positions 	6 and
	3 and a proline and a leucine residue in positions 2 and 4,
respectively (20).
In comparison with other tissues, AMPK in the kidney shows
distinctive features and has a high activity already under basal
conditions (see “Discussion”), making it a good candidate for
Cytc phosphorylation because we purified it directly from kid-
FIGURE 3. Structural and molecular dynamics analyses. A, chain A from the WT crystal structure (PDB entry 5C0Z) before (green) and after (cyan) 200 ns of
molecular dynamics are shown as C tracings superimposed using only main chain atoms. The hemes (Hec201) are shown in gray. The average Thr28 C
positions for the 39 intermediate 5-ns steps between the two end points are shown as spheres colored in a gradient from gray (5 ns) to red (195 ns). B, the mobile
loop (amino acids 22–30) from A is shown in greater detail after rotation by 90° about its horizontal axis to generate a “bottom-up” view. The C atoms for the
starting (Thr28) and ending (Thr28*) structures are colored blue. The intermediate C atoms (gray to red) all cluster about Thr28*, showing that the loop jumps
immediately to its minimum energy position and stays there. The distance between Thr28 C and Thr28* C is 4.5 Å. C, the RMSF for the first 100 ns (blue line)
and the second 100 ns (red line) by residue are plotted together. Two RMSF values (Lys27 and Ala44) are noticeably lower in the second 100 ns. D, chain A from
the T28A crystal structure (PDB entry 5C9M) before (green) and after (cyan) 200 ns of molecular dynamics. See A for details. E, equivalent to B, except the two
loops are from D. Over the 200 ns, the C atom of Ala28 pauses at four distinct intermediate positions before clustering around the final position. The distance
between Ala28 C and Ala28* C is 11.9 Å. F, equivalent to C for T28A Cytc. The RMSF values for Ala44 are lower in the second 100 ns, but those for Lys27 are
significantly higher in the second 100 ns, in fact the highest seen in all four RMSF plots. G, chain A from the T28E crystal structure (PDB entry 5DF5) before (green)
and after (cyan) 200 ns of molecular dynamics. See A for details. H, equivalent to B, except the two loops are from G. Over the 200 ns, the C atom of Glu28 clusters
at a midway position before moving to its final position near the end of the simulation. The distance between Glu28 C and Glu28* C is 7.2 Å. I, equivalent to
C for T28E Cytc. The RMSF values for Ala44 are of average size and similar for both halves of the simulation. The RMSF values for the loop containing Glu28 are
higher than average but similar for both halves of the simulation. J, the C tracings of chain A from the WT crystal structure (PDB entry 5C0Z) with a phosphate
group modeled onto Thr28 are shown superposed before (green) and after (cyan) 200 ns of molecular dynamics. See A for details. K, equivalent to B, except the
two loops are from J. Over the 200-ns period, the C atom of Thr(P)28 moves quickly to the final position and clusters around it. The distance between Xaa28
(X28) C and Xaa28* C is 5.2 Å. L, equivalent to C for the Tpo28 model. The RMSF values for the loop containing Glu28 are higher than average but similar for both
halves of the simulation.
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ney without manipulation of signaling pathways. To test
whether AMPK can phosphorylate Cytc, we first performed an
in vitro kinase assay with commercially available AMPK and
unphosphorylated WT Cytc as substrate. As shown in Fig. 5A,
Cytc was phosphorylated in a specific and AMPK-dependent
manner, which could be further accelerated by the addition of
AMPK activator AMP (Fig. 5B). We next confirmed by mass
spectrometry that Thr28 was the site of in vitro AMPK phos-
Cytochrome c Thr28 Phosphorylation
70 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 292 • NUMBER 1 • JANUARY 6, 2017
phorylation (Fig. 5C). For AMPK to phosphorylate Cytc in kid-
ney, the proteins have to physically interact inside the cell.
Under basal conditions, co-immunoprecipitation experiments
using extracts from total mouse kidney tissue as well as highly
purified mitochondria show interaction of AMPK with Cytc
(Fig. 6A). Furthermore, submitochondrial fractionation of
highly purified mitochondria indicates that AMPK and its acti-
vated phosphorylated form are present in the mitochondrial
intermembrane space (Fig. 6B, lane 2), as is Cytc. Finally, acti-
vation and inhibition of AMPK in mouse kidney tissue using
A769662 and Compound C, as confirmed by phosphorylation
of AMPK target phosphoacetyl-CoA carboxylase (Fig. 6C),
results in increased and decreased threonine phosphorylation
of Cytc, respectively (Fig. 6D), which inversely correlates with
intact mitochondrial respiration rates (Fig. 6E), mirroring data
presented in Figs. 1, 2, and 4. It is important to note that no such
effects were observed using liver tissue (data not shown), sug-
gesting tissue-specific differences in the regulation of Cytc,
which agrees with our previous studies demonstrating that liver
Cytc is Tyr48-phosphorylated.
Discussion
Little is known about the regulation of mitochondrial oxida-
tive phosphorylation by cell signaling. We have previously
reported two distinct tyrosine phosphorylation sites on Cytc
from mammalian heart and liver tissue. The current report
functionally characterizes a third tissue-specific phosphoryla-
tion site, Thr28, on Cytc purified from kidney. The same site was
also mapped, but not further studied, in a high throughput mass
spectrometry study using resting human skeletal muscle (21),
suggesting that Thr28 can be targeted to regulate ETC function
beyond kidney tissue. For the Cytc we isolated from kidney, the
majority (between 60 and 80%, depending on the prepara-
tion) of the protein is phosphorylated at Thr28. In addition, we
mutated Thr28 to phosphomimetic glutamate and non-phos-
phorylatable alanine to further characterize the effects of this
phosphorylation in vitro and in cultured murine lung fibroblast
cells lacking both Cytc isoforms.
Bovine in vivo phosphorylated and unphosphorylated Cytc as
well as overexpressed mouse WT, T28E, and T28A Cytc gener-
ated hyperbolic kinetics in the reaction with purified bovine
FIGURE 4. Introduction of phosphomimetic Cytc into Cytc knock-out cells leads to controlled respiration, intermediate mitochondrial membrane
potentials, and low ROS levels. A, Western blotting of Cytc double knock-out lung fibroblasts stably transfected with empty vector (EV) and WT, T28A, and
T28E expression constructs. B, proliferation rates of stably transfected lines were determined by cell counts; means  S.D. (error bars) are reported; *, p  0.05.
C, intact cell oxygen consumption rates (OCR) are decreased in both Cytc mutants. D, mitochondrial membrane potential as determined by JC-1 fluorescence
was decreased in cells expressing T28E versus WT and T28A Cytc. E, basal mitochondrial reactive oxygen species generation as determined with MitoSOX is
decreased in cells expressing T28E Cytc compared with WT. F, ATP levels determined with the bioluminescent method were decreased in cells expressing T28E
Cytc compared with WT. G, live cell counts after treatment with H2O2 indicate that T28E-expressing cells are better protected at intermediate H2O2 levels
compared with WT, whereas T28A-expressing cells show decreased survival at all concentrations compared with WT. Error bars, S.D.
FIGURE 5. AMPK phosphorylates Cytc on Thr28 in vitro. A, in vitro AMPK kinase assay with cow heart Cytc, conducted in the absence of AMPK activator AMP,
shows a time-dependent increase of threonine phosphorylation, as determined by Western blotting analysis. B, in vitro AMPK kinase assay with cow heart Cytc
shows an increase of threonine phosphorylation in the presence of AMPK activator AMP. C, Cytc subjected to an in vitro AMPK kinase assay as in A is
phosphorylated on Thr28 as determined by the nano-LC/ESI/MS/MS spectrum of HKpTGPNLHGLFGR. The phosphorylation site was unambiguously assigned
by fragment ions y10 and y11. The sequence of the peptide was assigned by b2, b8, b9, y2, y5, y6, y8, y9, and y10.
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liver CcO. Compared with WT, maximal turnover was reduced
by 50 and 73% for in vivo phosphorylated and phosphomimetic
Cytc, respectively. Furthermore, expression of phosphomi-
metic T28E Cytc led to a reduction of respiration in intact cells,
suggesting for the first time that modification of the small elec-
tron carrier can control overall ETC flux. These findings are
consistent with the concept that phosphorylation of mitochon-
drial proteins, in general, down-regulates whereas dephosphor-
ylation activates mitochondrial function (22). Reduced respira-
tion rates both in vitro with purified CcO and in intact cells
expressing T28E Cytc may be a result of the observed change in
the redox midpoint potential as well as of structural changes in
the protein. Thr28 lies in the center of an unusual structural
element termed the “negative classical  turn,” which is com-
posed of residues 27–29 and is important for the stability of
Cytc (23). Thr28 is a surface residue close to the solvent exposed
and accessible tip of the heme group that mediates electron
transfer to CcO. It is located on the frontal right side of the
molecule in the conventional view (Fig. 3A), which is part of the
circular, positively charged epitope surrounding the heme crev-
ice with which Cytc binds to the corresponding negatively
charged epitope on CcO (24). Interestingly, in this computa-
tional Cytc-CcO docking model, Thr28 is located at the inter-
face of catalytic subunits I and II and nuclear encoded subunit
VIIc, with closest distances of 6 Å to Lys47 of subunit VIIc and
of 7 Å to Asp50 of subunit I and Trp104 and Ser202 of subunit II
(supplemental Fig. 4G). Two of the four CcO residues are par-
ticularly noteworthy. Asp50 is one of only a handful of residues
in the entire CcO complex that have noticeably different geom-
etries between the reduced and oxidized state in the crystal
structure (25). In addition, Asp50 is located next to another
flexible amino acid, Asp51, which, when mutated to Asn, blocks
proton pumping of the enzyme and was proposed to be the
proton ejection site of CcO (26). Phosphorylation of Thr28 may
interfere with the outward movement of the Asp50-Asp51
region and thus the opening of the proposed proton exit chan-
nel during reduction of CcO. This would lead to inhibition of
CcO by inhibiting electron transfer-coupled proton pumping.
Alternatively, repulsion between phospho-Thr28 and Asp50
may result in suboptimal binding to CcO, causing reduced res-
piration rates. The second interesting interaction site on CcO is
Trp104, which is the site on CcO where electrons from Cytc
FIGURE 6. AMPK interacts with Cytc and localizes to the mitochondria. A, immunoprecipitation (IP) of AMPK from total mouse kidney extracts shows
interaction of AMPK with Cytc. B, submitochondrial fractionation of sucrose gradient purified mouse kidney mitochondria shows AMPK and phospho-AMPK
localization to the mitochondrial intermembrane space (IMS). Lane 1, mitochondrial lysate; lane 2, intermembrane space; lane 3, pellet after outer mitochondrial
membrane permeabilization containing outer mitochondrial membrane, mitoplasts, and residual IMS; lane 4, kidney tissue homogenate. C, incubation of
mouse kidney tissue with AMPK activator A769662 and inhibitor Compound C leads to activation and inhibition of AMPK, respectively, as deduced by AMPK
target phosphoacetyl-CoA carboxylase (p-ACC). D, pull-down of Cytc from mouse kidney tissue after treatment with AMPK activator A769662 and inhibitor
Compound C leads to an increase and decrease of Cytc threonine phosphorylation, respectively. E, incubation of mouse kidney tissue with AMPK activator
A769662 and inhibitor Compound C leads to decreased and increased intact mitochondrial respiration, as determined in tissue homogenates; means  S.D.
(error bars) are reported; *, p  0.05. F, model of the regulation of electron transport chain activity through phosphorylation of Cytc. Under healthy conditions,
Cytc is phosphorylated, leading to a partial inhibition of mitochondrial respiration. This in turn maintains healthy intermediate m values that are sufficient
for effective energy production but prevent the generation of ROS, which occurs at pathologically high m values.
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enter before reaching the first metal center, the binuclear CuA
site. Spatial interference upon Cytc Thr28 phosphorylation with
Trp104, which is essential for catalysis, could also explain
reduced activity.
We have previously shown that phosphomimetic Y48E Cytc
is incapable of downstream caspase activation (10). In contrast,
phosphorylation of Cytc Thr28 or its phosphomimetic substitu-
tion does not interfere with the ability of Cytc to trigger down-
stream caspase activation. This difference agrees with the
observation that the Tyr48 epitope is directly involved in the
interaction of Cytc with Apaf-1 whereas the Thr28 epitope is
not (27). This ability to similarly inhibit CcO activity but differ-
ently affect caspase activation is an example of tissue-specific
signaling, which in this case may result from AMPK isoform
expression in a tissue-specific manner.
A recent study compared 285 Cytc sequences across all phyla
from humans to bacteria (28). Overall, threonine is the most
common amino acid at position 28 and is conserved in mam-
mals. However, in some non-mammalian organisms, five other
amino acids can also be found, namely Gln, Val, Ile, Ser, and
even the phosphomimetic Glu, which is present in several
plants, including potatoes and tomatoes. Interestingly, alanine
is not among the residues evolutionarily tolerated in this posi-
tion. Another study using T28A mutant Cytc also reported
decreased respiration rates with CcO (29), confirming our
results. We found that T28A Cytc has a higher ability to activate
downstream caspases and unfolds more easily, which increases
CL oxidation. Its instability compared with WT and T28E Cytc
is also suggested in the respective circular dichroism spectra
(supplemental Fig. 1C, see lower wavelength range). In addi-
tion, T28A Cytc is most rapidly oxidized and degraded in the
presence of H2O2. Structural analysis of all three Cytc variants
shows that the amino acids comprising the negative classical 
turn element display by far the highest root mean square devi-
ation values compared with any other Cytc sequence, suggest-
ing that the Thr28 epitope is the most flexible element of the
entire molecule. A plot of the average temperature factors,
which for these high resolution structures are a reasonable mea-
sure of local mobility, also showed, other than at the termini,
that the highest relative values occurred at the 22–30 loop for
all three structures. Furthermore, molecular dynamics simula-
tions of crystalized T28A Cytc produce a structure in which the
Thr28 C atom is moved by 11.9 Å, approximately twice as far
compared with WT, T28E, and modeled phospho-Thr28 Cytc
(Fig. 3). These findings collectively suggest that alanine was
evolutionarily selected against because it introduces additional
flexibility at a site near the heme crevice, probably due to its
small size, leading to a detrimental reduction of protein stability
and interference with its multiple functions. This may also at
least in part account for the finding of lower Cytc protein levels
in cells expressing this mutant. Another evolutionarily forbid-
den substitution, T28D, which introduces a negative charge,
also generates “rogue” functional changes in Cytc, as seen in the
reaction with CcO, that are even opposite (29) of what we
report for in vivo phosphorylated Cytc, whereas glutamate
replacement, as used here, produces the same functional effects
as phosphorylated Cytc.
Our studies suggest that AMPK targets Cytc for Thr28 phos-
phorylation within the mitochondria. Future work using a
genetic approach should be conducted to confirm the role of
AMPK in Cytc phosphorylation. However, because kidneys
express both the AMPK-1 and -2 catalytic isoforms and
because their double knock-out results in embryonic lethality
(30), a more advanced approach would be necessary, such as a
tissue-specific knock-out.
AMPK is one of the most important and evolutionarily oldest
metabolic sensors and regulators (31). It is implicated in human
disease, including diabetes, where its activity is impaired in sev-
eral organs, including the kidneys (32). Generally, AMPK pro-
motes catabolic processes, and it is activated by phosphoryla-
tion and allosterically under conditions when ATP levels drop
and AMP levels increase. However, our understanding of the
role of AMPK specifically in the kidney is in its infancy (33), and
there are reports suggesting that it operates differently in this
organ compared with other tissues. For example, AMPK is
already active in the kidney under basal conditions and shows a
paradoxical decrease in activity in a rat kidney ablation and
infarction model (34), a condition when energy depletion and
thus demand is maximal. In cells from patients with hereditary
leiomyomatosis renal cell cancer, the Krebs cycle is inhibited,
which also leads to a paradoxical decrease of AMPK activity
(35). The high basal activity of AMPK also observed in this
study (Fig. 6, B and C) may be due to the fact that kidneys are
always active and rely heavily on oxidative phosphorylation
(12). Consistent with our findings that AMPK-mediated Cytc
phosphorylation partially suppresses mitochondrial respira-
tion, it was shown in human renal proximal tubular epithelial
cells that additional activation of AMPK with metformin
results in a significant reduction of cellular respiration (36).
The strong periodicity of kidney function (37, 38) (i.e. activity
oscillations controlled by circadian rhythm) provides a poten-
tial rationale for the buffering against rapid increase in ETC
activity, with attendant ROS increase, provided by the paradox-
ical AMPK response found in kidney. We thus propose a model,
shown in Fig. 6F, in which under physiological conditions a
central role of Cytc Thr28 phosphorylation in kidney is to main-
tain optimal intermediate m levels, which allow efficient
energy production but prevent ROS generation because ROS
are produced at high m levels (reviewed in Ref. 39). In line
with our concept, it was shown in cultured mouse proximal
tubular cells subjected to various forms of metabolic stress that
genetic or pharmacologic inhibition of AMPK caused apopto-
sis. Furthermore, in rats subjected to renal ischemia/reperfu-
sion injury, application of a high dose of AMPK activator
AICAR shortly before ischemia significantly improves cell sur-
vival (40). Cytc purified from ischemic kidney is dephosphor-
ylated (not shown), similar to Cytc isolated from ischemic brain
(41). This would allow maximal ETC flux, m hyperpolariza-
tion, and ROS production during reperfusion when ETC func-
tion is reinstated due to reintroduction of oxygen. We have
shown that neuroprotective insulin treatment before brain
ischemia/reperfusion leads to Cytc Tyr97 phosphorylation,
which also decreases respiration, resulting in suppression of the
release of Cytc from the mitochondria and a 50% reduction of
neuronal death (41). It will be interesting to see in future studies
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whether AICAR treatment maintains Cytc Thr28 phosphoryla-
tion during ischemia in the kidney, alleviating ETC hyperacti-
vation during reperfusion.
In conclusion, all three functionally studied Cytc phosphor-
ylations to date (Tyr97, Tyr48, and Thr28) lead to a partial inhi-
bition in the reaction with CcO, or “controlled respiration” (Fig.
6F). We propose that this mechanism provides a basis for the
maintenance of “healthy” intermediate m levels under nor-
mal conditions. This, in turn, prevents excessive ROS produc-
tion that occurs at high m levels under conditions of stress
when mitochondrial proteins become dephosphorylated,
allowing maximal ETC flux, m hyperpolarization, excessive
ROS, and cell death. Although all three known Cytc phosphor-
ylations limit respiration, the choice of site in a particular tissue
may depend on tissue-specific metabolic differences or on addi-
tional effects of the phosphorylation, such as regulation of
apoptosis.
Experimental Procedures
Isolation of Cytochrome c from Bovine Kidney Tissue—
Reagents and chemicals were purchased from Sigma unless
stated otherwise. All procedures involving animal tissues were
approved by the Wayne State University institutional animal
care and use committee. Kidneys from freshly slaughtered cows
were snap-frozen on dry ice and stored at 	80 °C until used for
Cytc purification by the acid extraction method at 4 °C or on ice
(9). Briefly, kidney tissues were homogenized in 100 mM phos-
phate buffer, pH 4.5, adjusted with acetic acid, and incubated
overnight at 4 °C. Under those conditions, most cellular pro-
teins denature and precipitate, whereas Cytc is extracted and
stays in solution. The homogenate was centrifuged at 15,810 

g for 35 min, supernatants were decanted through cheesecloth,
and pH was adjusted to 7.4 with KOH while simultaneously
adding protease (1 mM PMSF) and phosphatase inhibitors (10
mM KF, 1 mM sodium orthovanadate), thus preserving the phos-
phorylation state of Cytc. The supernatant was incubated at
4 °C for 20 min and centrifuged following ion exchange chro-
matography. First, the supernatant was passed through a DE52
anion exchange column equilibrated with 20 mM phosphate
buffer, pH 7.4, 3.6 millisiemens/cm conductance. Cytc was col-
lected in the flow-through, which was pH-readjusted to 6.5 and
applied to a CM52 cation exchange column equilibrated with
30 mM phosphate buffer, pH 6.5, 5.5 millisiemens/cm conduct-
ance. Cytc bound to the CM52 column was oxidized on the
column with 2 mM K3Fe(CN)6 and was eluted by step gradient
using 30, 50, 80, 120, and 150 mM phosphate buffers, pH 6.5. To
obtain a highly pure fraction of Cytc, the DE52 and CM52 ion
exchange chromatography steps were repeated. For further
purification, HPLC size exclusion chromatography with a col-
umn equilibrated with 150 mM phosphate buffer, pH 6.5, was
performed, and a mixture of phosphorylated and nonphosphor-
ylated Cytc was obtained. The protein was concentrated under
vacuum, desalted by centrifugation using Amicon Ultra-15 3
kDa centrifugal filter units (Millipore, Billerca, MA), and stored
at 	80 °C.
Protein Concentration and Purity Determination—Purified
Cytc was reduced with 100 mM sodium dithionite, desalted with
NAP-5 columns (GE Healthcare), and analyzed on a Jasco
V-570 double beam spectrophotometer (2-nm bandwidth).
The concentration was determined by differential spectra at
550 nm by subtracting the oxidized form from the reduced and
calculated via (reduced 	 oxidized)550 nm  19.6 mM	1 cm	1.
Purity of the protein was confirmed by Coomassie staining after
12% Tris-Tricine SDS-PAGE.
Gel Electrophoresis and Western Blotting—Western blotting
analyses were performed to analyze the phosphorylation status
of purified Cytc, with a 1:5,000 dilution of primary antibodies:
anti-phosphotyrosine (4G10, Millipore, Billerica, MA), anti-
phosphoserine (set of four individual monoclonal antibodies,
1C8, 4A3, 4A9, and 16B4; EMD Biosciences, Gibbstown, NJ),
and anti-phosphothreonine antibodies (set of three individual
monoclonal antibodies, 1E11, 4D11, and 14B3; EMD Biosci-
ences), followed by a 1:10,000 dilution of anti-mouse IgG or
IgM horseradish peroxidase-conjugated secondary antibody
(GE Healthcare). EGF-stimulated A431 total cell lysate
(Upstate, Billerica, MA) was used as a positive control, and
ovalbumin was used as a negative control. Note that sets of four
and three antibodies were used for phosphoserine and phos-
phothreonine detection, respectively, because these epitopes
are small and adjacent amino acids contribute to the binding of
the antibodies; using a mixture of different clones allows detec-
tion of phosphorylated serine and threonine residues in a broad
amino acid sequence context. Signal detection was performed
with an enhanced chemiluminescence method (GE Health-
care). The following antibodies were used at a dilution of
1:1,000: complex I NDUFB6 (MS108, MitoSciences, Eugene,
OR); complex II 70-kDa subunit (MS204, MitoSciences); com-
plex III core I (MS303, MitoSciences); complex IV subunit I
(MS404, MitoSciences); complex IV subunit IV (sc58348, Santa
Cruz Biotechnology, Inc., Dallas, TX); cytochrome c (556433,
BD Pharmingen, San Jose, CA); porin (MSA03, MitoSciences);
and GAPDH (ab9484, Abcam). To separate Thr28-phosphory-
lated from unphosphorylated Cytc, a 15% acrylamide, 2.6%
bisacrylamide gel (Tris-Tricine-SDS-PAGE) was prepared.
Cytc (500 ng) was denatured in 2
 sample buffer (NuPAGE,
NP0007, Invitrogen) with 100 mM DTT and 3% -mercapto-
ethanol. Cathode buffer was 100 mM Tris, 100 mM Tricine, 0.1%
SDS, and pH 8.25; anode buffer was 200 mM Tris-Cl pH 8.9; and
gels were run at a low voltage (80 V) for up to 4 h.
Mass Spectrometry of Purified Cytochrome c to Detect Site-
specific Phosphorylation—Phosphorylation site mapping on
purified kidney Cytc was performed after tryptic digestion and
TiO2 enrichment of phosphopeptides, following C18 reversed-
phase chromatography as described (41). Peptides were
injected into the mass spectrometer (LTQ Orbitrap-Velos,
Thermo Scientific, Waltham, MA) after electrospray ioniza-
tion. MS/MS spectra were obtained in positive ion mode,
assigned to peptide sequences from the UniProt protein data-
base, searched with the MASCOT algorithm for posttransla-
tional modifications, and manually verified.
Immunoprecipitation and Western Blotting Analyses from
Tissue Homogenates—All Western blotting analyses from tis-
sue homogenates were performed using 20 g of whole tissue
homogenates. All immunoprecipitations from tissue homoge-
nates were performed with 1 mg of tissue homogenate over-
night at 4 °C. For immunoprecipitations, 50 l of bead (Immu-
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noCruz IP/WB Optima E and F Systems, sc-45042 and
sc-45043) and 5 g of antibody were allowed to conjugate over-
night under rotation at 4 °C, centrifuged (22,000 
 g) for 30 s,
and washed twice with 500 l of PBS.
Mutagenesis, Expression, and Purification of Cytochrome c
Variants—Mouse somatic Cytc cDNA was cloned into the
pLW01 expression vector (kind gift from Dr. Lucy Waskell,
University of Michigan) that also contained the cDNA encod-
ing heme lyase (CYC3), an enzyme necessary for the covalent
attachment of the heme group to apo-Cytc. Thr28 in the wild
type Cytc cDNA was mutated to the phosphomimetic gluta-
mate and nonphosphorylatable alanine as an additional con-
trol. Forward primers 5-AAGCATAAGGAGGGACCAAA-3
(Tm  53.8 °C) and 5-AAGCATAAGGCTGGACCAAA-3
(Tm  53.8 °C) and corresponding reverse and complement
primers 5-TTTGGTCCCTCCTTATGCTT-3 (Tm  54.6 °C)
and 5-TTTGGTCCAGCCTTATGCTT-3 (Tm  54.6 °C)
were used for T28E and T28A mutagenesis PCR, respectively,
as described (10). The outer primers that amplified the entire
Cytc cDNA sequence containing NcoI and BamHI restriction
sites were 5-AATTTACCATGGGTGATGTTGAAAAAG-3
(Tm  56.7 °C) and 5-AATAAAGGATCCAGTGGAAT-
TATTCAT-3 (Tm  54.7 °C), respectively. The mutated Cytc
cDNA sequences were subcloned into the pLW01 bacterial
expression plasmid after restriction digestion with NcoI and
BamHI. Note that the Cytc cDNA contains an internal NcoI
restriction site; thus, the fragments were first fully digested with
BamHI following partial (3-min) digestion with NcoI and puri-
fication of the correct size fragment after agarose gel electro-
phoresis. Constructs were confirmed by sequencing and used
to transform competent E. coli C41 (DE3) cells for protein over-
expression (10). The clones were inoculated into 20 ml of TB
medium (Difco) containing 100 g/ml carbenicillin and grown
overnight at 37 °C under shaking. These cultures were used to
inoculate 4 liters of 100 g/ml carbenicillin-containing TB
medium and were grown until an A600 of 2–3 was reached. At
this time, the expression of cytochrome c was induced by the
addition of 100 M isopropyl -D-1-thiogalactopyranoside, and
the protein was overexpressed for 6 h at 37 °C. The cells were
harvested by centrifugation for 40 min at 8,400 
 g, 4 °C, and
the pellets were immediately stored at 	80 °C until used for
Cytc extraction. The bacterial pellets were resuspended in lysis
buffer containing 20 mM phosphate buffer, pH 7.4, supple-
mented with a protease inhibitor mixture (P8340, Sigma) as
recommended by the manufacturer. For every 10 g of bacterial
pellet, 100 ml of lysis buffer were used, and the resuspended
cells were lysed using a French pressure cell press (AMINCO,
American Instrument Co.). The lysates were centrifuged at
15,000 rpm for 45 min, the pH of the supernatant was adjusted
to 7.4, and Cytc variants were purified by ion exchange chro-
matography as described above for kidney Cytc isolation. For
expression of Cytc variants in Cytc double knock-out mouse
lung fibroblasts (15), the pBABE-puro expression plasmid
(Addgene, Cambridge, MA) was used. A similar PCR mutagen-
esis approach was performed as above, and fragments were
cloned into the BamHI and EcoRI restriction sites using
the following primers: outer forward primer pBABE,
5-ATCTTGTGGAAAGGACGCGGGATCCATGGGTGAT-
GTTGAAAAA-3 (Tm  68.0 °C); outer reverse primer pBABE,
5-GGTCGACCACTGTGCTGGCGAATTCTTACTTATC-
GTCGTCATCCTTGTAATCTTCATTAGTAGCC-3 (Tm 
68.8 °C). The resultant C-terminal 1
FLAG-tagged wild-type,
T28E phosphomimetic mutant, and T28A non-phosphorylatable
mutant constructs were transfected into Cytc double knock-out
lung fibroblast cells and cultured in DMEM (high glucose, Gibco
BRL), supplemented with 10% fetal bovine serum, 1,000 units of
penicillin/streptomycin, 1 mM pyruvate, 50 g/ml uridine at 37 °C
and 5% CO2. Stable cell lines expressing the three Cytc variants as
well as an empty vector control cell line were selected in the pres-
ence of 4 g/ml puromycin.
CD Spectroscopy—CD spectra of cytochrome c variants (wild
type, T28A, T28E, and bovine heart cytochrome c (Sigma))
were recorded on a Jasco J-815 spectrometer using a 0.6-mm
path length quartz cuvette. Proteins were diluted to 220 M
final concentration in 100 mM phosphate buffer, pH 7.4, and 1
ml of protein solution was reduced with 250 M ascorbate. An
average of three scans were collected at 20 °C at a resolution of
1 nm.
Crystallization of WT, T28A, and T28E Cytochrome c and
Data Analysis—Cytc was gel-filtered on a S100 column to
reduce aggregates and concentrated to 15 mg/ml in water. To
establish a defined oxidation state, the proteins were oxidized
with 5 mM K3Fe(CN)6 before crystallization. Crystals were
grown by vapor diffusion after mixing 1 l of protein solution
with 1 l of precipitant solution and equilibrating the drop
against 0.5 ml of the precipitant at room temperature. The
respective precipitant solutions for crystals of the WT, T28A,
and T28E Cytc are listed in supplemental Table 1. Crystals usu-
ally appeared within 1 week. Crystals were soaked for 10 min in
a cryo-protectant solution (supplemental Table 1) before flash
freezing in liquid nitrogen. Single crystal diffraction data were
collected at the Life Sciences Collaborative Access Team facil-
ity (Advanced Photon Source sector 21, Argonne National Lab-
oratory). The data were collected over a full 360° rotation in
either 0.6 or 1.0° frames and integrated using XDS (42) in Auto-
Proc (43). For structure solution and refinement, the native
data set was solved using chain A of the human Y48F Cytc
structure (PDB entry 3ZOO) (44) in PHENIX (45). It was refit
with AutoBuild in the PHENIX suite and refined with PHENIX
initially to obtain occupancies for the FC6 molecules. The
refinement was completed to an Rfree of 0.159 at 1.12 Å resolu-
tion with REFMAC5 (46) in CCP4 using refinement parameters
and weights optimized with PDB_REDO (47). In particular,
PDB_REDO recommended anisotropic temperature factors
based on the Hamilton ratio test for all three structures. Elec-
tron density was analyzed with COOT (48) in the CCP4 suite of
crystallographic programs (49). The FC6 ligands were located
and placed in an anomalous diffraction difference map with
COOT. Using the WT structure as an example, the highest
eight peaks (in order) in the map, are the four heme iron atoms,
followed by FC6 202/C, FC6 202/B, FC6 202b/A, and FC6
203b/B. The next three peaks are for three sulfur atoms
(Cys14/A, Cys17/B, Met80/D) followed by FC6 202a/A and FC6
202a/B. The last two FC6 positions were included because they
had sufficient 2Fo 	 Fc density to fit several of their cyanide
groups. The WT structure (PDB entry 5C0Z; 1.12 Å; Rfree 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0.159) was then used to solve, refit, and refine the structures of
the T28A (PDB entry 5C9M) and T28E (PDB entry 5DF5)
mutants at 1.36 Å (Rfree  0.170) and 1.30 Å (Rfree  0.178)
resolution, respectively.
Molecular Dynamics and ESP Calculations—Molecular
dynamics were performed with YASARA (50) using its conserv-
ative “slow” protocol and the recommended default force field,
AMBER 2003 (51). The RMSF and average structures plotted in
Fig. 3 were calculated with default scripts in the YASARA
library. ESPs in vacuo were calculated with YASARA to high-
light the charge distribution using the recommended NOVA
force field (52) and the particle mesh Ewald algorithm (53). The
rectangular simulation cell for the ESP calculations was 15 Å
from all atoms in the tetramer. No ligands were included in the
calculation. Molecular images including the superpositions
were calculated in YASARA (50). Plots were generated with
Excel using data imported from YASARA. The three electron
density plots in Fig. 3 were assembled with PyMOL (version 1.8;
Schrödinger, LLC, New York) using electron density calculated
by COOT. The final assembly of all figures was done in
Photoshop.
Measurement of Cytc Redox Potential—The midpoint redox
potential (E0) was analyzed spectrophotometrically as de-
scribed (10) using 2,6-dichloroindophenol (DCIP, E0  237
mV) as a reference compound, which has an absorption band at
600 nm in its oxidized state. One ml of Cytc solution (2 mg/ml)
was mixed in a spectrophotometric cuvette with 2 ml of 50 mM
citrate buffer, pH 6.5, 0.1 ml of 1 mM DCIP, and 50 l of 1 mM
K3Fe(CN)6 to fully oxidize Cytc. Absorbances corresponding to
fully oxidized Cytc (A550–A570) and DCIP (A600) were recorded
using a Jasco V-570 double beam spectrophotometer. The mix-
ture was then sequentially reduced by 1-l additions of 5 mM
ascorbate (pH 6.5), and absorbance values were acquired at
each step. When readings became constant, a few grains of
sodium dithionite (Na2S2O4) were added to fully reduce Cytc
and DCIP. For each step, ratios of oxidized and reduced forms
of both compounds were calculated. Data obtained were plot-
ted as log(DCIPOX/DCIPRED) versus log(CytOX/CytRED), yield-
ing a linear graph with a slope of n-DCIP/n-Cytc and a y axis
intercept of n-Cytc/59.2(E Cytc 	 E DCIP). These values were
used to calculate the E0 (mV) of Cytc from the Nernst equation.
CcO Activity Measurements—Briefly, an aliquot of regulatory
competent bovine liver CcO, which has the same isozyme com-
plement as kidney CcO, was diluted to 3 M final concentration
in the presence of a 40-fold molar excess of cardiolipin and 0.2
mM ATP in CcO measuring buffer (10 mM K-HEPES (pH 7.4),
40 mM KCl, 1% Tween 20) and dialyzed overnight at 4 °C to
remove cholate bound to CcO during enzyme purification. Res-
piration of CcO (150 nM) was analyzed in a closed chamber
equipped with a micro-Clark-type oxygen electrode (Oxygraph
system, Hansatech, Pentney, UK) at 25 °C in 220 l of CcO
measuring buffer and 20 mM ascorbate as electron donor.
Increasing amounts of purified Cytc variants (0 –25 M) were
added, and oxygen consumption was recorded and analyzed
with the Oxygraph software (Hansatech). CcO activity was
expressed as turnover number (s	1).
Caspase-3 Activation by Cytc Variants—Caspase-3 activity
was assessed in vitro with cytoplasmic extracts of a mouse lung
fibroblast cell line lacking both the somatic and testis-specific
Cytc genes (15) as described (10). Briefly, cells from eight
150-mm plates were collected by centrifugation at 4 °C. The
pellet was washed once in 5 ml of ice-cold cytosol extraction
buffer (20 mM HEPES, pH 7.5, 10 mM KCl, 1.5 mM MgCl2, 1 mM
EDTA, 1 mM EGTA, 1 mM dithiothreitol, 1 mM PMSF), resus-
pended gently in the same buffer, and immediately transferred
to an ice-cold Dounce homogenizer. After 15 min of swelling on
ice, cells were then broken open with a B-type glass pestle, and
cell breakage was confirmed using a microscope. The lysates
were transferred to microcentrifuge tubes and centrifuged at
4 °C and 15,000 
 g for 15 min to remove nuclei and other
debris. The protein concentration of the cytosolic fraction-con-
taining supernatant was measured using the DC assay kit (Bio-
Rad), and cytosolic extracts were diluted to 2 mg/ml. The
EnzChek caspase-3 assay kit (Invitrogen) with rhodamine 110-
linked DEVD tetrapeptide, an artificial substrate for caspase-3
that fluoresces upon cleavage, was used. Cytosolic extracts
from Cytc double knock-out lung fibroblast cells (2 mg/ml con-
centration) were incubated with the Cytc variants (15 g/ml)
for 2.5 h at 37 °C. Caspase-3 activity was assessed in the pres-
ence or absence of the caspase-3 inhibitor by detection of fluo-
rescence from the cleavage of the artificial caspase-3 substrate
over 3 h in 30-min intervals using a Fluoroskan Ascent FL plate
reader (Labsystems, Thermo Scientific), 485-nm excitation fil-
ter (14-nm bandwidth), and 527-nm emission filter (10-nm
bandwidth). The amount of cleaved substrate was calculated
from the rhodamine 110 calibration curve, and data were
expressed in pmol of cleaved DEVD min	1 (mg of protein)	1.
Measurement of Rates of Oxidation and Reduction—The
kinetics of oxidation of 15 M ferro-Cytc with 100 M H2O2 and
reduction of 15 M ferri-Cytc with 200 M ascorbate was mea-
sured spectrophotometrically at 550 nm as described (54).
Briefly, WT Cytc and T28E and T28A Cytc mutants were
reduced with sodium dithionite, and the proteins were sepa-
rated from the reductant through NAP5 columns. Fifteen M
Cytc in 0.2 M Tris-Cl, pH 7.0, was incubated with 100 M oxi-
dizing agent H2O2, and after 10 s, the decrease of the absorption
peak at 550 nm was measured, and the amount of oxidized Cytc
was calculated as described above. To measure the kinetics of
reduction of Cytc with ascorbate, Cytc variants were fully oxi-
dized with K3Fe(CN)6 and purified using NAP5 columns. Fif-
teen M ferri-Cytc was added to 50 mM sodium phosphate, pH
7.0, and 200 M ascorbate to a cuvette, which was then sealed
from air, and the initial rate of reduction was measured at 550
nm.
Peroxidase Activity of Cytc Mutants—Assessment of peroxi-
dase activity (10) with Amplex Red reagent was performed by
measuring the fluorescence of resorufin, an oxidation product
of Amplex Red. Cytc (1 M) was incubated with liposomes con-
taining TOCL/1,2-dioleoyl-sn-glycero-3-phosphocholine in a
1:1 ratio for 10 min. The peroxidase reaction was started by the
addition of Amplex Red (50 M) and H2O2 (50 M) and was
carried out for 20 min, during which the reaction rate was lin-
ear. Fluorescence was detected by employing a “Fusion R” uni-
versal microplate analyzer by using an excitation wavelength of
535 nm and an emission wavelength of 585 nm.
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Heme Degradation Assay—The degradation of heme was
analyzed through dissipation of the Soret band at 408 nm using
5 M ferri-Cytc from in 50 mM phosphate buffer, pH 6.1, with 3
mM H2O2 as described (54). Spectra were scanned initially after
60 s, followed by measurements every 200 s.
In Vitro Phosphorylation of Cytochrome c with AMP Kinase—
Cow heart Cytc (300 pmol; Sigma) was incubated with 3 pmol of
AMPK (AMPK 1/1/1, Active SignalChem, P47-10H) at
37 °C for 5 or 30 min in the presence and absence of AMP (125
M) in 25 mM MOPS (pH 7.2), 12.5 mM -glycerophosphate, 25
mM MgCl2, 2 mM EDTA, 0.25 mM DTT, and 1 mM ATP. Sam-
ples were analyzed by Western blotting and mass spectrometry.
Tissue Treatments with AMPK Activator A769662 and Inhib-
itor Compound C and Western Blotting Analyses—Fresh mouse
kidneys were placed in ice-cold ST buffer containing 250 mM
sucrose, 20 mM Tris, pH 7.4, 10 mM KF, 1 mM PMSF, 1 mM
sodium orthovanadate, supplemented with protease inhibitor
mixture (Sigma) and phosphatase inhibitor mixtures 2 (P5726,
Sigma) and 3 (P0044, Sigma) according to the manufacturer’s
protocol. Kidneys were immediately minced with scissors on an
ice-cold glass plate, and equal weight (80 mg) was placed in
tubes containing 2 ml of buffer following treatment with either
500 M A769662 (AMPK activator, Tocris, 3336), 3 M Com-
pound C (AMPK inhibitor, Sigma, P5499), or DMSO (solvent
control) for 1 h at 37 °C under shaking. Tubes were put on ice,
tissues were pelleted by centrifugation, and buffer was replaced
with 1 ml of homogenization buffer (50 mM Tris-Cl, pH 7.5, 1
mM EGTA, 1% Triton-X 100, 1 mM sodium orthovanadate, 50
mM KF, 5 mM sodium pyrophosphate, 0.27 M sucrose, 0.1%
-mercaptoethanol, supplemented with protease inhibitors
and phosphatase inhibitor mixtures as above) and homoge-
nized using a Teflon Dounce homogenizer by applying 60
strokes. Homogenates were centrifuged at 22,000 
 g at 4 °C for
30 min, and supernatants’ total protein levels were quantitated
using the DC protein assay kit (Bio-Rad). Twenty g of tissue
homogenates were loaded for immunoblotting analyses to
check for total and phospho-AMPK levels and phosphoacetyl-
CoA carboxylase levels (AMPK1/2 antibody (H-300),
sc-25792; phospho-AMPK1/2 antibody (Thr172), sc-33524,
Santa Cruz Biotechnology; p-acetyl-CoA carboxylase (Ser79)
antibody 3661, Cell Signaling Technology (Danvers, MA); anti-
body dilution 1:1,000). Subsequently, 1 mg of homogenate was
used for overnight immunoprecipitation of Cytc. A 10% Tris-
Tricine-SDS-PAGE was run to analyze total and phospho-
AMPK levels, phospho-ACC levels, and threonine phosphor-
ylation of immunoprecipitated Cytc (using a 1:250 dilution of a
set of three individual monoclonal anti-phosphothreonine
antibodies (1E11, 4D11, and 14B3), EMD Biosciences). In addi-
tion, AMPK was immunoprecipitated from kidney homoge-
nates after treatment with 500 M A769662 for 1 h to analyze
Cytc co-immunoprecipitation.
Measurement of Mitochondrial Oxygen Consumption Rate of
Tissue Homogenates—Respiration of intact mitochondria in
tissue homogenates was determined as described (55), using
freshly harvested kidney tissues, following treatment with
AMPK activator and inhibitor as above after homogenization in
homogenization buffer with 10 strokes. The protein concentra-
tion was determined using the DC protein assay kit (Bio-Rad),
and diluted to 0.2 mg/ml with KCl buffer (80 mM KCl, 10 mM
Tris-HCl, 3 mM MgCl, 1 mM EDTA, 5 mM potassium phos-
phate, 2.5 mM malate, 0.5 mg/ml BSA, pH 7.4). Mitochondrial
respiration was measured at 30 °C using a Clark-type oxygen
electrode as described above.
Sucrose Density Gradient Isolation of Mitochondria and
Subfractionation—Lung fibroblasts were harvested and resus-
pended in 10 mM NaCl, 1.5 mM MgCl2, 10 mM Tris-Cl, pH 7.5.
They were allowed to swell for 5 min on ice and homogenized
using a Teflon-glass homogenizer. The sucrose concentration
was adjusted to 250 mM by adding 2 M sucrose and TE buffer (10
mM Tris-Cl, 20 mM EDTA, pH 7.6). The homogenate was cen-
trifuged twice at 1,300 
 g for 3 min, and the supernatant was
collected and centrifuged at 15,000 
 g for 10 min and washed
three times with 250 mM sucrose/TE buffer. The mitochondrial
fraction was layered on a discontinuous sucrose gradient con-
taining 1 M sucrose and 1.7 M sucrose in TE buffer. Centrifuga-
tion was performed at 70,000 
 g for 40 min at 4 °C, and mito-
chondria were retrieved from the interface. Mitochondria were
washed in 250 mM sucrose/TE buffer and collected by centrif-
ugation at 22,000 
 g for 15 min to obtain highly pure mito-
chondria. The mitochondrial pellet was resuspended in 20 mM
sodium phosphate buffer, pH 7.2, 0.02% BSA, and allowed to
swell for 20 min on ice, and then 1 mM ATP and 1 mM MgCl2
were added, followed by incubation on ice for 5 min and cen-
trifugation at 15,000 
 g for 10 min at 4 °C. The supernatant
contained the intermembrane space fraction, and the pellet
contained mitoplasts, the outer membrane fraction, and the
residual intermembrane space fraction.
Isolation and Subfractionation of Mitochondria from Mouse
Kidneys—Mouse kidneys were freshly harvested and washed in
ice-cold isolation buffer (10 mM Tris, 1 mM EGTA, 200 mM
sucrose, pH 7.4 adjusted with MOPS) (56). Kidneys were
minced with scissors on an ice-cold glass plate and homoge-
nized with 20 strokes using a Dounce homogenizer on ice. The
homogenate was centrifuged at 600 
 g for 10 min, and the
supernatant was centrifuged at 7,000 
 g for 10 min to pellet
mitochondria. The mitochondrial pellet was subfractionated
into an intermembrane space fraction and a mitoplast and
outer membrane fraction as described above. The fractions
were subjected to Western blotting analysis with Cytc, AMPK,
phospho-AMPK, and additional control antibodies to demon-
strate purity of the fractions.
Measurement of Oxygen Consumption Rate in Intact Cells—
Per well, 70,000 cells were cultured in growth medium (DMEM,
supplemented with 10% FBS, 1000 units of penicillin/strepto-
mycin, 1 mM pyruvate, and 50 g/ml uridine) using Seahorse
XFe24 plates. After overnight culture, growth medium was
replaced with XF medium, pH 7.4, and intact cell respiration
was measured.
ATP Assay—Lung fibroblast cells expressing Cytc variants
were scraped and collected and immediately stored at 	80 °C
until measurement. Release of ATP was performed by boiling
after the addition of 300 l of boiling buffer (100 mM Tris-Cl,
pH 7.75, 4 mM EDTA) and immediate transfer of the samples to
a boiling water bath for 2 min. Samples were put on ice, soni-
cated, and diluted 300-fold, and 40 l of the diluted samples
were used to determine the ATP concentration with the ATP
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bioluminescence assay kit HS II (Roche Applied Science)
according to the manufacturer’s protocol. Data were stan-
dardized to the protein concentration.
Measurement of m—Lung fibroblast cells expressing Cytc
variants were grown to 80% confluence. To assess relative
changes in m, cells were incubated for 30 min in phenol
red-free medium containing 1 M JC-1 (Molecular Probes).
JC-1 is able to selectively enter mitochondria, is a monomer at
low concentration or at low membrane potential, and emits
green fluorescence. At higher membrane potential, JC-1 forms
aggregates that emit red fluorescence. Cells were washed with
PBS, and fluorescence was measured with an Ascent Fluoros-
kan plate reader by using an excitation wavelength of 485 nm
and an emission wavelength of 590 nm for red aggregates and
527 nm for green monomers.
Mitochondrial ROS Measurement—Cells expressing Cytc
variants were cultured in 12-well plates and incubated with 5
M Mitosox for 30 min in at 37 °C. Cells were washed with PBS,
and fluorescence was analyzed with a Synergy H1 plate reader
(BioTek, Winooski, VT) by using excitation and emission wave-
lengths of 510 and 590 nm.
Cell Viability—Cells (100,000 cells/well in 6-well plates)
expressing Cytc variants were grown for 48 h and trypsinized,
and live cells were counted after staining with trypan blue. For
cell viability analyses after treatment with H2O2, cell number
was doubled, and cells were treated with 50 and 300 M H2O2
for 24 h followed by trypan blue staining.
Statistical Analyses—Statistical analyses were performed
using MSTAT version 5.4 (N. Drinkwater, University of Wis-
consin) in conjunction with the Wilcoxon rank sum test. Data
(n  3–5) are reported as means  S.D. and were considered
statistically significant (*) with p  0.05.
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